CA2395006A1 - Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production - Google Patents

Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production Download PDF

Info

Publication number
CA2395006A1
CA2395006A1 CA002395006A CA2395006A CA2395006A1 CA 2395006 A1 CA2395006 A1 CA 2395006A1 CA 002395006 A CA002395006 A CA 002395006A CA 2395006 A CA2395006 A CA 2395006A CA 2395006 A1 CA2395006 A1 CA 2395006A1
Authority
CA
Canada
Prior art keywords
phenyl
bis
methylethyl
carbon atoms
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002395006A
Other languages
English (en)
French (fr)
Inventor
Reynold Homan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of CA2395006A1 publication Critical patent/CA2395006A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CA002395006A 2001-08-01 2002-07-25 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production Abandoned CA2395006A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30933601P 2001-08-01 2001-08-01
US60/309,336 2001-08-01

Publications (1)

Publication Number Publication Date
CA2395006A1 true CA2395006A1 (en) 2003-02-01

Family

ID=23197778

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002395006A Abandoned CA2395006A1 (en) 2001-08-01 2002-07-25 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production

Country Status (11)

Country Link
US (1) US20030134898A1 (OSRAM)
EP (1) EP1281399A3 (OSRAM)
JP (1) JP2003104878A (OSRAM)
KR (1) KR20030013289A (OSRAM)
CN (1) CN1404829A (OSRAM)
CA (1) CA2395006A1 (OSRAM)
HU (1) HUP0202548A2 (OSRAM)
IL (1) IL150918A0 (OSRAM)
NZ (1) NZ520487A (OSRAM)
PL (1) PL355281A1 (OSRAM)
ZA (1) ZA200206032B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
DK1673077T3 (da) 2003-10-09 2008-12-08 Warner Lambert Co Farmaceutiske præparater, der omfatter malonamidderivater til at nedsætte talgproduktion
EP2942349A1 (en) 2004-12-23 2015-11-11 Deciphera Pharmaceuticals, LLC Enzyme modulators and treatments
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
WO2008131276A1 (en) 2007-04-20 2008-10-30 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
NZ603654A (en) 2008-10-29 2014-09-26 Deciphera Pharmaceuticals Llc Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
CN109071454B (zh) 2016-02-16 2023-02-17 昆士兰大学 磺酰脲和相关化合物及其用途
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
CN118416236A (zh) 2018-01-31 2024-08-02 德西费拉制药有限责任公司 治疗胃肠道间质瘤的组合疗法
NZ766710A (en) 2018-01-31 2025-08-29 Deciphera Pharmaceuticals Llc Combination therapy for the treatment of mastocytosis
MX2021001754A (es) * 2018-08-15 2021-04-19 Inflazome Ltd Compuestos de sulfonamidaurea novedosos.
PL3983387T3 (pl) 2019-06-12 2024-08-19 NodThera Limited Pochodne sulfonylomocznika i ich zastosowania
TWI878335B (zh) 2019-08-12 2025-04-01 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
KR20220045189A (ko) 2019-08-12 2022-04-12 데시페라 파마슈티칼스, 엘엘씨. 위장관 기질 종양을 치료하는 방법
HRP20231699T1 (hr) 2019-12-30 2024-05-10 Deciphera Pharmaceuticals, Llc Formulacije inhibitora amorfne kinaze i postupci njihove primjene
MX2022008097A (es) 2019-12-30 2022-09-19 Deciphera Pharmaceuticals Llc Composiciones de 1-(4-bromo-5-(1-etil-7-(metilamino)-2-oxo-1,2-dih idro-1,6-naftiridin-3-yl)-2-fluorofeil)-3-fenilurea.
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
US5254715A (en) * 1990-11-07 1993-10-19 Warner-Lambert Company Aminosulfonyl carbamates
US5214206A (en) * 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
US5198466A (en) * 1990-11-09 1993-03-30 Warner-Lambert Company Oxysulfonyl urea acat inhibitors
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
US6730703B2 (en) * 2000-02-02 2004-05-04 Warner-Lambert Company Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
US6514489B1 (en) * 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
AU2002240235B2 (en) * 2001-01-30 2006-07-06 Merck & Co., Inc. Acyl sulfamides for treatment of obesity, diabetes and lipid disorders

Also Published As

Publication number Publication date
KR20030013289A (ko) 2003-02-14
HUP0202548A2 (hu) 2003-02-28
JP2003104878A (ja) 2003-04-09
IL150918A0 (en) 2003-02-12
HU0202548D0 (OSRAM) 2002-10-28
EP1281399A2 (en) 2003-02-05
NZ520487A (en) 2004-03-26
EP1281399A3 (en) 2004-02-11
US20030134898A1 (en) 2003-07-17
ZA200206032B (en) 2004-02-10
PL355281A1 (en) 2003-02-10
CN1404829A (zh) 2003-03-26

Similar Documents

Publication Publication Date Title
CA2395006A1 (en) Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
CA2087251C (en) Pharmaceutical compositions
US5252604A (en) Compositions of retinoic acids and tocopherol for prevention of dermatitis
DE69813935T2 (de) Verwendung von Retinoiden zur Induzierung von Hautpigmentierung
PL180746B1 (pl) Związki polienowe oraz zawierające je kompozycje farmaceutyczne i kosmetyczne
US20120282314A1 (en) Dermatological/cosmetic skin depigmenting compositions
PT1761266E (pt) Compostos, formulações, e métodos para tratamento ou prevenção de distúrbios inflamatórios da pele
US20130178446A1 (en) Method for decreasing sebum production
JP2013502411A (ja) ヘキサミジン類とレチノイド類を含有する皮膚改善組成物
DE69500576T2 (de) Verwendung eines Ethylendiaminderivats in einer kosmetischen und/oder dermatologischen Zusammensetzung und Zusammensetzung, die insbesondere ein Produkt mit reizender Nebenwirkung enthaelt
AU2002306767B2 (en) Topical dapsone for the treatment of acne
EP0628308B1 (en) Use of O-esters of L-carnitine with aromatic acids for the treatment of dermatoses
US6730703B2 (en) Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
US8821904B2 (en) Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
US4654354A (en) Retinoic acid derivatives, process for their preparation and pharmaceutical and cosmetic compositions containing them
US20130165526A1 (en) Topical treatment with dapsone in g6pd-deficient patients
US20090298868A1 (en) Quinoline compounds as melanogenesis modifiers and uses thereof
DE69309029T2 (de) Nonatetraensäurederivate
US20090137569A1 (en) Administration of (3S)-N-hydroxy-4-(sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (S)-N_hydroxy-4-[4_(but-2-ynyloxy)phenylsulfonyl]-2,2-dimethyl thimomorpholine-3-carboxamide for preventing and/or treating inflammatory skin pathologies/afflictions
WO2021203136A1 (en) Methods for treating hyperpigmentation and compositions for same
US9822136B2 (en) Chemical inhibitors of sebocyte function
JP2013001655A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued